Skip to main content
Uncategorized

GAEM, finalist of Farmaindustria’s ‘2010 Awards to the Best Patient Service Initiatives’

By 19 de November de 2010November 18th, 2020No Comments
< Back to news
 19.11.2010

GAEM, finalist of Farmaindustria’s ‘2010 Awards to the Best Patient Service Initiatives’

The Foundation of People Affected by Multiple Sclerosis (GAEM), based at the Barcelona Science Park, has been selected as a finalist for the ‘2010 Awards to the Best Patient Service Initiatives' granted by the Farmaindustria Foundation, in the category of "Commitment to Research". These awards aim to recognize the social activities that are conducted by certain organizations and/or people for the benefit of individuals affected by different diseases, support the best initiatives targeting these groups in the field of health, and stimulate practices that improve the quality of life of patients.

These awards, which are celebrating their 6th edition this year, are structured in five categories, aimed at: patient associations –where the GAEM’s candidacy lies-, social groups, the health care setting, communication media and personal trajectory. The awards, endowed with 30,000 Euros and two second prizes of 3,000 Euros in each category, will be delivered in a ceremony that will take place next December 15 in Madrid

At present the GAEM promotes two research projects aimed at finding a new treatment for multiple sclerosis: CELLTRiMS, which was started last year and which aims to use a type of stem cell from the patient to stop the rejection of his or her own myelin; and TOLERVIT, the objective of which is to transplant dendritic cells, the type of cells most directly involved in the rejection of myelin and its destruction, to patients.

In addition to the GAEM, the Multiple Sclerosis Unit of the Germans Trias i Pujol University Hospital, the Laboratory of Immunobiology for Research and Diagnostic Applications (Lirad) and the Division of Advanced Therapies of the Blood and Tissue Bank are also participating in both projects. Both projects have been publicly and privately by the Carlos III Institute, the Ministry of Science and Innovation and TV3’s Marató Foundation.